Tetra Bio-Pharma Submits Request for Scientific Advice to Malta Medicines Authority

April 28, 2021 2:00 AM

Tetra plans for global commercialization of QIXLEEF OTTAWA, ON / ACCESSWIRE / April 28, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a leader in cannabinoid-derived drug discovery and development announced today that it has submitted a request to the Malta Medicines Authority for a Scientific Opinion on its investigational new drug (IND) QIXLEEF for Tetra's clinical...

Read more

Vitro Biopharma Inc. January 31st 2021, 1st Quarter ended Financial Results of Operations and Shareholder Letter

April 27, 2021 6:00 PM

GOLDEN, CO / ACCESSWIRE / April 27, 2021 / Vitro Biopharma Inc. (formerly Vitro Diagnostics Inc.) (dba Vitro Biopharma), announced its quarter ended January 31st, 2021, financial results of operations. Vitro Biopharma recorded quarter ended January 31st, 2021 revenues of $ 127,492 vs $225,921 a decrease of 44% over the prior comparative quarter directly attributed to the COVID-19 pandemic. Revenues in the first quarter of 2021 of $127,492...

Read more

Invest Africa Global Receives Its First Covid-19 Rapid Test Kit In Namibia, Africa

April 27, 2021 7:30 AM

Invest Africa Global Receives Its First Covid-19 Rapid Test Kit In Namibia, Africa CHEYENNE, WY / ACCESSWIRE / April 27, 2021 / MJ Biotech, Inc. (OTC PINK:MJTV), the first shipment to Invest Africa Global of Covid 19 Rapid Test Kit arrived at Namibia, Africa April 23, 2021. The Rapid Test kit is a Nasal Swab test that produces test results in 10 minutes. This is an exciting time for the Company and for Invest Africa Global, as well. The...

Read more

Experion to Present at the Emerging Growth Conference on April 28, 2021

April 26, 2021 8:45 AM

VANCOUVER, BC / ACCESSWIRE / April 26, 2021 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) Canada's solution to craft cannabis supply and builder of premium cannabis brands including its sought after and popular brand Citizen Stash announced today that its CEO, Mr. Jarrett Malnarich, has been invited to present live at the Emerging Growth Conference on April 28,...

Read more

Kinarus Further Strengthens Its Leadership with Two Reputed Industry Experts

April 26, 2021 8:00 AM

Hari Kumar, former CEO of Adheron Therapeutics, Inc. appointed Chairman of the Board of Directors Thierry Fumeaux, MD, former member of Swiss National Covid Taskforce, joined Kinarus as new Chief Medical Officer BASEL, SWITZERLAND / ACCESSWIRE / April 26, 2021 / Kinarus AG, a Swiss clinical-stage biopharmaceutical company and owner of KIN001, a differentiated therapeutic candidate for the treatment of multiple diseases with high unmet...

Read more

Pieris Pharmaceuticals and Boston Pharmaceuticals Enter into an Exclusive Worldwide Product License for PRS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific

April 26, 2021 8:00 AM

Pieris will receive $10 million upfront and be entitled to receive additional milestone payments and tiered royalties Boston Pharmaceuticals will be primarily responsible for development of the program, with both parties collaborating during the investigational new drug (IND)-enabling stage BOSTON and CAMBRIDGE, MA / ACCESSWIRE / April 26, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) and Boston Pharmaceuticals today announced that...

Read more

Nascent Biotech Announces Pre-emptive Elimination of Significant Tranche of Convertible Debt

April 26, 2021 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / April 26, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology company pioneering the development of monoclonal antibodies targeting treatment of various cancers and viral infections, is pleased to announce that It has paid off and eliminated a major convertible debt note, pre-emptively preventing a dilutive...

Read more

Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa Presents VenoValve One Year First-In-Human Data at Charing Cross International Symposium

April 23, 2021 12:40 PM

IRVINE, CA / ACCESSWIRE / April 23, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that Dr. Jorge Hernando Ulloa, the Principal Investigator for HJLI's first-in-human VenoValve® study in Bogota, Colombia, presented one year data this past week at the Charing Cross International Symposium. The Charing Cross International Symposium is the...

Read more

Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial

April 23, 2021 9:00 AM

First clinical study to assess cannabis as an alternative to morphine Tetra completes manufacturing of QIXLEEF clinical trial drug for REBORN1 trial Export permit received from Health Canada for immediate shipping to USA OTTAWA, ON / ACCESSWIRE / April 23, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a leader in cannabinoid-derived drug discovery and development is...

Read more

THC Therapeutics Has Completed the dHydronator(R) Consumer Model Design

April 23, 2021 8:33 AM

THCT has leveraged the extensive market research commissioned through Keyhole Research to redesign the dHydronator® for the consumer market. This new design is in the rapid prototyping phasein preparation for mass manufacturing. LAS VEGAS, NV / ACCESSWIRE / April 23, 2021 / THC Therapeutics, Inc. (OTC PINK:THCT), a forward-thinking, publicly-traded technology company, whose mission statement is, "Better Health through the...

Read more

ITOCO Welcomes Mr. Hadelin Carlos Diericx Trouyet to Its Board of Directors

April 23, 2021 8:00 AM

TORONTO, ON / ACCESSWIRE / April 23, 2021 / ITOCO INC. (OTC PINK:ITMC) is pleased to announce that Mr. Hadelin Carlos Diericx Trouyet has joined the firm's Board of Directors. Mr. Diericx is a results-driven, highly-accomplished, and focused serial entrepreneur with 25 years of experience. He brings strong leadership skills, dedication and discipline, with broad experience in business development. He charted growth paths for several...

Read more

Molecular Partners Files Registration Statement for Proposed Initial Public Offering in the United States

April 23, 2021 1:00 AM

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / April 23, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to a proposed initial public offering of its American...

Read more

Qrons Announces U.S. Patent Office Grants Dartmouth College 3D Printing Patent Forming Basis of License Agreement with Qrons

April 22, 2021 9:00 AM

NEW YORK, NY / ACCESSWIRE / April 22, 2021 / Qrons Inc. (OTCQB:QRON), an innovative biotechnology company developing next generation treatments for unmet neuronal diseases, using tissue engineering, stem cells and machine learning synergic technologies is proud to report that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,954,315 to the Trustees of Dartmouth College which is directed to mechanically...

Read more

Edesa Biotech to Host Key Opinion Leader Webinar on EB05 for the Treatment of Acute Respiratory Distress Syndrome

April 22, 2021 8:00 AM

Virtual event scheduled for Thursday, April 29 at 1 pm Eastern Time TORONTO, ON / ACCESSWIRE / April 22, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that it will host a key opinion leader (KOL) webinar on EB05, the company's lead asset for the treatment of Acute Respiratory Distress Syndrome (ARDS), on Thursday, April 29, 2021 at...

Read more

Lexaria Commences Human Clinical Hypertension Study

April 22, 2021 7:00 AM

Study to examine DehydraTECHTM CBD's ability to control blood pressure First of three human clinical studies hoped to validate Lexaria's patented technology for hypertension relief KELOWNA, BC / ACCESSWIRE / April 22, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that its human...

Read more

HMNC Brain Health Embarks on Next Phase of Growth with New Leadership Team

April 22, 2021 4:50 AM

Benedikt von Braunmühl named new CEO Dr. Hans Eriksson appointed Chief Clinical Development Officer Dr. Franz Humer strengthens Board of Directors as Chairman Founder Prof. Dr. Dr. Dr. h.c. mult. Florian Holsboer to lead Scientific Advisory Board MUNICH, GERMANY / ACCESSWIRE / April 22, 2021 / HMNC Brain Health, a biotech company focused on the development of innovative and personalized treatments for depression and other...

Read more

Apollo Endosurgery Announces Publication of Pre-Clinical Results for X-Tack(TM) Endoscopic HeliX Tacking System

April 21, 2021 4:15 PM

Authors conclude, "Compared to TTS clip, X-Tack is superior for effecting large mucosal defect closure, including durable sealing of full-thickness perforation." AUSTIN, TX / ACCESSWIRE / April 21, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the publication of supporting pre-clinical results for the...

Read more

Oncology Pharma, Inc. Prepares Plan Toward Funding Development and Implementation of Ribera Solutions' Patient Engagement and Retention Platform

April 21, 2021 10:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / April 21, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is moving ahead with advancing its efforts with Ribera Solutions' Conect2Med platform with Oncology Pharma's exclusivity for oncology, including drug development, clinical trials, personalized oncology and therapeutics. Ribera has been developing its platform and Oncology Pharma, under its License...

Read more

Shareholders of Molecular Partners AG Approve all Board Proposals at the Annual General Meeting; Agnete Fredriksen and Dominik Höchli Elected New Board Members

April 21, 2021 9:00 AM

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / April 21, 2021 / At today's AGM of Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, the shareholders of the company approved all motions proposed by the Board of Directors with a very large majority. In light of the current COVID-19 situation and in line with the applicable Swiss...

Read more

MJ Biotech Partner Genesis Botanical Signs An Additional Three Hemp Farmers, Securing 115 Additional acres of Hemp Biomass for CBD Extraction

April 21, 2021 7:30 AM

CHEYENNE, WY / ACCESSWIRE / April 21, 2021 / MJ Biotech, Inc. (OTC PINK:MJTV), is pleased to report its CBD Extraction partner, Genesis Botanical Research (GBR), has secured another 115 acres of hemp biomass to extract bringing the total amount to 155 acres with the 40 acres previously secured. GBR has contacted and had communications with less than 15% of the entire list of licensed hemp growers in the state of Maine. More contracts are...

Read more